Cargando...
The neoepitope landscape of breast cancer: implications for immunotherapy
BACKGROUND: Cancer immunotherapy with immune checkpoint blockade (CKB) is now standard of care for multiple cancers. The clinical response to CKB is associated with T cell immunity targeting cancer-induced mutations that generate novel HLA-binding epitopes (neoepitopes). METHODS: Here, we developed...
Guardado en:
| Publicado en: | BMC Cancer |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6399957/ https://ncbi.nlm.nih.gov/pubmed/30832597 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5402-1 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|